METiS TechBio has teamed up with Lilly in a deal worth $1.1bn, pairing AI-driven lipid design with pharma expertise to ...

Dan is currently a trade media relations expert at Sartorius, a life science research and biopharmaceutical technology provider. He formerly led the news domain of Bioprocess International. He has ...

IQVIA and Veeva extend their partnership, expanding sponsor access to Veeva's clinical trial and data management technology.

BioXconomy highlights leading Black innovators and leaders in the biotechnology industry.

Germany’s Merck has agreed to acquire London-based Silence Therapeutics in an all-cash deal, adding a late-stage rare blood ...

The clinical-stage biotech has closed an oversubscribed Series D financing round in a bid to meeting its mission to stop ...

Estuary Biotherapeutics launches with $103 million to take gene therapies for kidney disease into the clinic. The financing ...

Labcorp acquires BioReference Health assets from OPKO for $722 million, expanding reach of its FDA-approved 4Kscore prostate ...

Biopharma finance leaders detail how they build and refine gross-to-net models amid shrinking margins across biopharma ...

AstraZeneca pays $40 million upfront to put insitro's AI platform to work on metabolic dysfunction-associated steatohepatitis ...

Zealand Pharma has signed a multi-target collaboration with Generate Biomedicines to design protein therapeutics for obesity ...

The collaboration will integrate AI more directly into scientific instrumentation, aiming to close the gap between ...